Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 183,452 | 197,672 | -2,964 | 4,639 | -47,579 |
| Depreciation Amortization | 676 | 741 | 547 | 326 | 1,012 |
| Accounts receivable | -2,543 | -2,449 | -3,001 | -3,160 | -6,737 |
| Accounts payable and accrued liabilities | -27,654 | -26,306 | -21,692 | -24,766 | 14,512 |
| Other Working Capital | -153,032 | -148,190 | 12,139 | -5,652 | -117,459 |
| Other Operating Activity | -5,673 | -7,914 | 30,372 | 31,332 | 18,252 |
| Operating Cash Flow | $-4,774 | $13,554 | $15,401 | $2,719 | $-137,999 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -61,158 | -3,035 | N/A | N/A | -8,628 |
| PPE Investments | -38 | -38 | -29 | -16 | 780 |
| Net Acquisitions | 96,615 | 90,204 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 133,841 |
| Investing Cash Flow | $35,419 | $87,131 | $-29 | $-16 | $125,993 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -80,560 | -80,554 | -2 | -5 | -40 |
| Common Stock Issued | N/A | N/A | N/A | -46 | 139 |
| Other Financing Activity | -5,468 | -5,460 | -95 | -37 | -354 |
| Financing Cash Flow | $-86,028 | $-86,014 | $-97 | $-88 | $-255 |
| Exchange Rate Effect | 1,077 | 1,126 | 2,388 | 1,407 | 751 |
| Beginning Cash Position | 102,178 | 102,178 | 102,178 | 102,178 | 113,688 |
| End Cash Position | 47,872 | 117,975 | 119,841 | 106,200 | 102,178 |
| Net Cash Flow | $-54,306 | $15,797 | $17,663 | $4,022 | $-11,510 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,774 | 13,554 | 15,401 | 2,719 | -137,999 |
| Capital Expenditure | -38 | -38 | -29 | -16 | -266 |
| Free Cash Flow | -4,812 | 13,516 | 15,372 | 2,703 | -138,265 |